313 related articles for article (PubMed ID: 15751768)
1. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; Morsica G; Pizzaferri P; Ladisa N; Sighinolfi L; Chiodera A; Solmone M; Lalle E; Ippolito G; Monforte Ad; ;
Antivir Ther; 2005; 10(1):109-17. PubMed ID: 15751768
[TBL] [Abstract][Full Text] [Related]
2. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
3. Characterization of GBV-C infection in HIV-1 infected patients.
Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
[TBL] [Abstract][Full Text] [Related]
4. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
[TBL] [Abstract][Full Text] [Related]
6. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients.
Rodriguez B; Woolley I; Lederman MM; Zdunek D; Hess G; Valdez H
J Infect Dis; 2003 Feb; 187(3):504-7. PubMed ID: 12552436
[TBL] [Abstract][Full Text] [Related]
7. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study.
Van der Bij AK; Kloosterboer N; Prins M; Boeser-Nunnink B; Geskus RB; Lange JM; Coutinho RA; Schuitemaker H
J Infect Dis; 2005 Mar; 191(5):678-85. PubMed ID: 15688280
[TBL] [Abstract][Full Text] [Related]
8. Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART.
Björkman P; Flamholc L; Molnegren V; Marshall A; Güner N; Widell A
AIDS; 2007 Jul; 21(12):1641-3. PubMed ID: 17630561
[TBL] [Abstract][Full Text] [Related]
9. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of circulating natural type 1 interferon-producing cells in HIV/GBV-C and HIV/HCV coinfected patients: a preliminary study.
Haji Molla Hoseini M; Pourfathollah AA; Mohraz M; Soheili Z; Amini S; Aghaiepour M; Samiee S; Nikoogoftar M; Meshkani R
Arch Med Res; 2007 Nov; 38(8):868-75. PubMed ID: 17923269
[TBL] [Abstract][Full Text] [Related]
11. Impact of GB virus C viraemia on clinical outcome in HIV-1-infected patients: a 20-year follow-up study.
Ernst D; Greer M; Akmatova R; Pischke S; Wedemeyer H; Heiken H; Tillmann HL; Schmidt RE; Stoll M
HIV Med; 2014 Apr; 15(4):245-50. PubMed ID: 24118889
[TBL] [Abstract][Full Text] [Related]
12. Impact of GB virus type C infection on mother-to-child HIV transmission in the Women and Infants Transmission Study Cohort.
Handelsman E; Cheng I; Thompson B; Hershow R; Mofenson LM; Hollinger FB; Chen KT; Burchett SK; Klinzman D; Stapleton JT;
HIV Med; 2007 Nov; 8(8):561-7. PubMed ID: 17944690
[TBL] [Abstract][Full Text] [Related]
13. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
[TBL] [Abstract][Full Text] [Related]
14. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
[TBL] [Abstract][Full Text] [Related]
15. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
[TBL] [Abstract][Full Text] [Related]
16. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.
Brumme ZL; Chan KJ; Dong WW; Mo T; Wynhoven B; Hogg RS; Montaner JS; O'Shaughnessy MV; Harrigan PR
AIDS; 2002 Sep; 16(14):1929-33. PubMed ID: 12351953
[TBL] [Abstract][Full Text] [Related]
17. Infection with GB virus C and reduced mortality among HIV-infected patients.
Tillmann HL; Heiken H; Knapik-Botor A; Heringlake S; Ockenga J; Wilber JC; Goergen B; Detmer J; McMorrow M; Stoll M; Schmidt RE; Manns MP
N Engl J Med; 2001 Sep; 345(10):715-24. PubMed ID: 11547740
[TBL] [Abstract][Full Text] [Related]
18. Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection.
Mosam A; Sathar MA; Dawood H; Cassol E; Esterhuizen TM; Coovadia HM
AIDS; 2007 Jun; 21(10):1377-9. PubMed ID: 17545721
[TBL] [Abstract][Full Text] [Related]
19. Frequency and genotype of GB virus C among Iranian patients infected with HIV.
Hekmat S; Mohraz M; Vahabpour R; Jam S; Bahramali G; Banifazl M; Aghakhani A; Eslamifar A; Mahboudi F; Edalat R; Ramezani A
J Med Virol; 2008 Nov; 80(11):1941-6. PubMed ID: 18814233
[TBL] [Abstract][Full Text] [Related]
20. Influence of hepatitis G virus (GB virus C) on the prognosis of HIV-infected women.
Campos AF; Tengan FM; Silva SA; Levi JE
Int J STD AIDS; 2011 Apr; 22(4):209-13. PubMed ID: 21515753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]